FDA — authorised 24 December 1984
- Application: NDA019125
- Marketing authorisation holder: XTTRIUM
- Status: supplemented
FDA authorised Antiseptic Solution on 24 December 1984
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 24 December 1984; FDA has authorised it.
XTTRIUM holds the US marketing authorisation.